Montelukast Sodium Tablet, Chewable
Product Images NDC 63187-550

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 63187-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart (Montelukastcombine Figure 01)

The text is a chart depicting the change in height in centimeters for two groups of individuals categorized as "Monseliéas Soden § g" (n=130) and "Placebs" (n=121) over a period of weeks on treatment with "Becomethasone". No further information is available.*

FDA Label Image

Str (Montelukastcombine Figure 02)

FDA Label Image

Chart2 (Montelukastcombine Figure 03)

The text represents a statistical analysis of the mean percent change from baseline over the course of 15 weeks of treatment with either placebo or montelukast sodium. The percentage change is measured at weeks 2, 6, 12, and 15. The text is a table that appears to display the findings of the analysis.*

FDA Label Image

Logo (Montelukastcombine Figure 04)

FDA Label Image

Table (Montelukastcombine Figure 05)

This text appears to be a list of potential symptoms that a person might experience when using medication or drugs. Some of the symptoms include aggression, bad dreams, depression, confusion, anxiety, hallucinations, irritability, memory problems, restlessness, sleepwalking, suicidal thoughts and tremors. These symptoms can be serious and should be reported to a healthcare professional immediately.*

FDA Label Image

Logo (Montelukastcombine Figure 06)

FDA Label Image

63187-550-30 (Montelukastcombine Figure 07)

This is a description of a medication called Montelukast Sodium 4mg, available in chewable tablets. The details of this medication include the NDC code, lot number, and expiry date. The physical description of the tablets includes their size, shape, color, and any markings on them. The medication is for prescription-only use, and the package was manufactured by ProficientRx and distributed by TORRENT PHARMACEUTICALS LTD in India. It is advised to store the medication at a certain temperature and keep it out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.